109 related articles for article (PubMed ID: 25975111)
1. [Umifenovir (Arbidol) efficacy in experimental mixed viral and bacterial pneumonia of mice].
Leneva IA; Falynskova IN; Leonova EI; Fedyakina IT; Makhmudova NR; Osipova EA; Lepekha LN; Mikhailova NA; Zverev VV
Antibiot Khimioter; 2014; 59(9-10):17-24. PubMed ID: 25975111
[TBL] [Abstract][Full Text] [Related]
2. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
[TBL] [Abstract][Full Text] [Related]
3. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
[TBL] [Abstract][Full Text] [Related]
5. A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severity.
McHugh KJ; Mandalapu S; Kolls JK; Ross TM; Alcorn JF
PLoS One; 2013; 8(12):e82865. PubMed ID: 24324838
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret).
Wang Y; Ding Y; Yang C; Li R; Du Q; Hao Y; Li Z; Jiang H; Zhao J; Chen Q; Yang Z; He Z
Biomed Pharmacother; 2017 Jul; 91():393-401. PubMed ID: 28475918
[TBL] [Abstract][Full Text] [Related]
7. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
[TBL] [Abstract][Full Text] [Related]
8. Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.
Harada T; Ishimatsu Y; Hara A; Morita T; Nakashima S; Kakugawa T; Sakamoto N; Kosai K; Izumikawa K; Yanagihara K; Mukae H; Kohno S
J Pharmacol Exp Ther; 2016 Sep; 358(3):457-63. PubMed ID: 27489022
[TBL] [Abstract][Full Text] [Related]
9. Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.
Fukushi M; Yamashita M; Miyoshi-Akiyama T; Kubo S; Yamamoto K; Kudo K
PLoS One; 2012; 7(8):e42419. PubMed ID: 22879974
[TBL] [Abstract][Full Text] [Related]
10. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia.
Robinson KM; Lee B; Scheller EV; Mandalapu S; Enelow RI; Kolls JK; Alcorn JF
Respir Res; 2015 Feb; 16(1):10. PubMed ID: 25651926
[TBL] [Abstract][Full Text] [Related]
11. [Anti-viral activity of a complex of the glycyrrhizic acid-alpha-glutamyltryptophan against the experimental lethal influenza infection in white mice caused by the oseltamivir-resistant strain of the virus].
Smirnov VS; Garshinina AV; Shtro AA; Anikin VB; Galochkina AV; Beliavskaia SV; Zarubaev VV
Vopr Virusol; 2014; 59(5):31-8. PubMed ID: 25895209
[TBL] [Abstract][Full Text] [Related]
12. Lianhuaqingwen capsule inhibits non-lethal doses of influenza virus-induced secondary Staphylococcus aureus infection in mice.
Song J; Zhao J; Cai X; Qin S; Chen Z; Huang X; Li R; Wang Y; Wang X
J Ethnopharmacol; 2022 Nov; 298():115653. PubMed ID: 35995276
[TBL] [Abstract][Full Text] [Related]
13. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
[TBL] [Abstract][Full Text] [Related]
14. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
[TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model.
Jiang T; Zhao H; Li XF; Deng YQ; Liu J; Xu LJ; Han JF; Cao RY; Qin ED; Qin CF
Antiviral Res; 2011 Jan; 89(1):124-6. PubMed ID: 21115063
[TBL] [Abstract][Full Text] [Related]
16. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
17. [EFFECTIVENESS OF FULLERENE-(TRIS-AMINOCAPRONIC ACID) HYDRATE IN THE MODEL OF EXPERIMENTAL VIRAL-BACTERIAL PNEUMONIA OF MICE].
Falynskova IN; Leonova EI; Fedyakina IT; Makhmudova NR; Lepekha LN; Mikhailova NA; Rasnetsov LD; Zverev VV; Leneva IA
Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):32-9. PubMed ID: 26829851
[TBL] [Abstract][Full Text] [Related]
18. Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.
Tsai AW; McNeil CF; Leeman JR; Bennett HB; Nti-Addae K; Huang C; Germann UA; Byrn RA; Berlioz-Seux F; Rijnbrand R; Clark MP; Charifson PS; Jones SM
Antimicrob Agents Chemother; 2015 Oct; 59(10):6007-16. PubMed ID: 26169418
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions.
Brooks MJ; Burtseva EI; Ellery PJ; Marsh GA; Lew AM; Slepushkin AN; Crowe SM; Tannock GA
J Med Virol; 2012 Jan; 84(1):170-81. PubMed ID: 22028179
[TBL] [Abstract][Full Text] [Related]
20. [Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice].
Zarubaev VV; Garshinina AV; Kalinina NA; Shtro AA; Beliaevskaia SV; Nebol'sin VE; Kiselev OI
Antibiot Khimioter; 2010; 55(5-6):24-31. PubMed ID: 21033471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
